Managing Hospital Safety: Common Safety Concerns, Part 4 of 4
This week we wrap up our Homerun Slides series on Managing Hospital Safety with a focus on the steps you can take to mitigate the widespread problems of insulin errors in the hospital....
Pramlintide, Part 2
This week, we have the second and last of our two-part Homerun Slides series on Pramlintide, covering safety issues and providing some guidelines for prescribing this important medication....
Pramlintide, Part 1 of 2
This week we begin a special two-part series of Homerun Slides on Pramlintide, starting with a pharmacodynamic review of this important drug and also its efficacy and safety in relation to type 1 diabetes in...
Hypo and Hyperglycemia, Part 4
This week, we continue our Homerun Slides series on Hypo and Hyperglycemia focusing in on Hypoglycemia in the hospital. Although hypoglycemia is easily treatable, the medications used are also subject ...
Hypo and Hyperglycemia, Part 3
In this week's Homerun Slides, we cover how to help patients determine the correct time and amount of insulin dosage, examine the perils of sliding scales, and also give you the basics on how to deal with...
Hypo and Hyperglycemia, Part 2
This week, we have Part 2 of our Homerun Slides on Hypo and Hyperglycemia focusing on how different types of insulin can result in various effects which if not managed correctly, may result in...
Diabetes Mellitus 101 for Medical Professionals, PART 9
This week we wrap up our nine-part series of Homerun Slides on An Aggressive Pathophysiologic Approach to Cardiometabolic Therapy for Type 2 Diabetes with information on Therapy for Type II Diabetes,...
Diabetes Mellitus 101 for Medical Professionals, PART 8
In this week's Homerun Slides, Part 8 of Dr. Stanley Schwartz's series on An Aggressive Pathophysiologic Approach to Cardiometabolic Therapy for Type 2 Diabetes, we continue with our discussion last...
Diabetes Mellitus 101 for Medical Professionals, Part 7
In this week's continuation of our Homerun Slides series from Dr. Stanley Schwartz, we delve into the effects of Ranolazine on A1c and some of the studies done exploring the CV effects as well ....
Diabetes Mellitus 101 for Medical Professionals, Part 6
In this week's Homerun Slides, we present Part 6 of Dr. Stanley Schwartz's series on An Aggressive Pathophysiologic Approach to Cardiometabolic Therapy for Type 2 Diabetes, in which we will...
Diabetes Mellitus 101 for Medical Professionals, PART 5
In this week's Homerun Slides, we cover such topics as the Potential Mechanisms of reducing CV outcomes with DPP-4 inhibitors, Mechanisms of Incretins, and Insulin Secretagogues: Sulfonylureas and...
Diabetes Mellitus 101 for Medical Professionals, PART 4
In this week's Homerun Slides, we continue with Part 4 of our series from Dr. Stanley Schwartz on An Aggressive Pathophysiologic Approach to Cardiometabolic Therapy for Type 2 Diabetes. This week's ...
Incretins, Part 7 of 7
This week, we wrap up our seven part series of Homerun Slides on Incretins with a discussion of Incretin Therapy and Type 2 Diabetes Mellitus...
Incretins, Part 6 of 7
This week's slide set includes slides on GLP-1 and the Central Nervous System, the Cardiac Actions of GLP-1, and the Emerging Roles of Bioactive GLP-1 Metabolites, plus more....
Incretins, Part 5 of 7
In this week's Homerun Slides, Incretins, Part 5 of 6, we review the tissue-specific differences in the mechanisms of action of GLP-1 analogs, DPP-4 inhibitors, and GLP-1R agonists and also discuss the...
The Role of DPP-IV Inhibitors in the Management of Type 2 Diabetes
Incretins, Part 3 of 7
This week we continue our six part series on Incretins with Homerun Slides focused on Sitagliptin....
Incretins, Part 2 of 7
This week with Part 2 of our new Incretins series of Homerun Slides, we cover "Incretin Physiology in Type 2 Diabetes Mellitus" and "GLP-1 & GIP Secretion in Type 2 Diabetes Mellitus"....
Incretins, Part 1 of 7
This first of seven sets of Homerun Slides begins with GLP-1 physiology, then examines the actions of DPP-4 inhiitors and GLP-1R agonists, plus....
Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 5
This week we conclude our five-part series of Homerun Slides on Pathophysiology in the Treatment of Type 2 Diabetes: New Agents. This week's slides include coverage of Liraglutide and...
Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 4
This week we continue with Part 4 of our series of Homerun Slides on Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents. Slides this week cover Exenatide, a synthetic version of...
Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 3
We continue this week with our Homerun Slides series on Pathophysiology in the Treatment of Type 2 Diabetes: Newer...
Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 2
This week we continue our series of Homerun Slides on Pathophysiology in the Treatment of Type 2 Diabetes: New Agents with information on Colesevelam....
Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 1
This week we begin a new five-part Homerun Slides series on Pathophysiology in the Treatment of Type 2 Diabetes focusing on Newer Agents, including Bromocriptine....
GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 4
This week we wrap-up our four part series on GLP-1 Agonists. Topics covered this week include: "Treatment with Exenatide does not impair the counterregulatory glucagon response," "Incretin-related Anti-diabetes...
In this week's Homerun Slides, we provide you with Part 2 of A Teaching Resource Guide from Novo Nordisk to give your patients the tools they need to keep on track with their diabetes management. Topics...
A Teaching Resource Guide, Part 1 of 2
Our Homerun Slides set this week, A Teaching Resource Guide, Part 1 of 2, is geared toward patient education and comes courtesy of Novo Nordisk. The program covers medications, hypoglycemia, nutrition, physical...
Managing Hospital Safety: Common Safety Concerns, Part 3 of 4
This week we bring you Part 3 of our Homerun Slides on Hospital Safety, homing in especially on Managing Patient Safety: High-Risk Medications in the Hospital Setting....
Managing Hospital Safety: Common Safety Concerns, Part 2
In this week's Homerun Slides selection, we continue our series on hospital safety with topics including "Never" Events, Responsibility for Maintaining Hospital Safety, and some of the Major Safety ...
Managing Hospital Safety: Common Safety Concerns, Part 1
In this week's Homerun Slides, we begin a new series on Hospital Safety. Topics covered this week include Medication Errors and Needlestick Injuries....
In this week's Homerun Slides, we cover how to help patients determine the correct time and amount of insulin dosage, examine the perils of sliding scales, and also give you the basics on...
Hypo and Hyperglycemia, Part 2
This week, we have Part 2 of our Homerun Slides on Hypo and Hyperglycemia focusing on how different types of insulin can result in various effects which if not managed...
Hypo and Hyperglycemia, Part 1
This week we begin a new Homerun Slides series covering Hypo and Hyperglycemia from our Editor-in-chief, Dave Joffe, BSPharm, CDE, FACA, which will include facts and figures on this burgeoning...
Diabetes Mellitus 101 for Medical Professionals, PART 1
This week we begin a new Homerun Slides series on Diabetes Mellitus 101 for Medical Professionals: An Aggressive Pathophysiologic Approach to Cardiometabolic Therapy for Type 2 Diabetes created by...
Sleep Apnea
If your diabetes patients have sleep apnea, they may also have hypertension....
Diabetes Mellitus 101 for Medical Professionals, PART 3
In this week's set of Homerun Slides, we discuss whether it is possible to delay the onset of type 2 DM and explore the effects of some medications on obesity...
Diabetes Mellitus 101 for Medical Professionals, PART 2
In this week's set of Homerun Slides, Diabetes Mellitus 101 for Medical Professionals: An Aggressive Pathophysiologic Approach to Cardiometabolic Therapy...
Overview of AGEs, Part 4
This week we wrap-up our four-part series of Homerun Slides covering AGEs, with slides on Supplements, Pharmacological Agents Under Investigation, More Common Pharmacological Agents, and Metabolic Activation...
Overview of AGEs, Part 3
This week we continue our Homerun Slides series on Advanced Glycation End-products (AGEs) with Part 3, covering the Primary Sources for AGEs, and Reducing or Negating the Effects of AGEs....
Overview of AGEs, Part 2
In this week's set of Homerun Slides, we review AGEs and their relation to complications of diabetes including retinopathy, nephropathy, neuropathy and macrovascular disease....
Overview of AGEs, Part 1
This week we begin a new Homerun Slides series on advanced glycation end-products (AGEs) focusing on gaining insight into understanding the formation of (AGEs), their overall impact on diabetic patients, and ...
Incretins, Part 4 of 7
In this week's Homerun Slides, we cover DPP-IV inhibitors including a comparison of effects with GLP-1 receptor agonists....
Navigate through our listing of Homerun Slides: Clinical presentation library articles here.
78
Total articles for Homerun Slides: Clinical presentation library
DISCLAIMER: The content of this Website is independent of the views of our advertisers and sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.
Copyright @ 1999-2012 Diabetes In Control, Inc.. All rights reserved.
Entries (RSS News)
